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Abstract 
BACKGROUND: Radical cystectomy is the standard treatment for nonmetastatic bladder cancer (muscle-
invasive and selective superficial bladder cancer). There are many types of urinary diversion after this procedure; 
the ileal conduit is the most and simplest one.  
AIM: To asses clinical, pathological profile, early complication, functional and oncological outcome after radical 
cystectomy and ileal conduit for muscle-invasive bladder cancer patients. 
METHOD: Between January 2013 and December 2016, there were 68 patients diagnosed with bladder cancer. 
From those patients, 24 (35.29%) patients had been performed radical cystectomy with ileal conduit type for 
urinary diversion (100%). Patients demographic, clinical and pathological profile, early postoperative complication, 
functional and oncological outcome were collected from the medical record. 
RESULT: Among the 24 patients who underwent radical cystectomy, 20 patients were male (83.3%) with the 
mean age was 57.3 y.o (33–77 y.o). Twelve patients (50%) showed pT4 and pT2 respectively. Based on 
pathological result 20 patient (83.34%) had the urothelial carcinoma, three patients (12.5%) had squamous cell 
carcinoma, and one patient (4.1%) had adenocarcinoma. Two patients (8.3%) got neoadjuvant chemotherapy, 
and nine patient (37.5%) of patients followed adjuvant chemotherapy after surgery. Wound dehiscence, fistula 
enterocutan, prolong ileus, leakage anastomosis and sepsis were kind of complication after surgery. One year's 
survival rate is 84%, mortality rate 20.8% and a recurrence rate of 20.8% in 4 years follow up. 
CONCLUSION: Radical cystectomy and ileal conduit type of urinary diversion still become the preferable 
procedure for nonmetastatic bladder cancer with good functional and oncological outcome. 
 
 
 
 
 
Introduction 
 
Radical cystectomy with bilateral pelvic 
lymphadenectomy is the standard treatment for 
muscle-invasive and high-risk non-muscle-invasive 
urothelial carcinoma of the bladder. There are 
numerous choices for urinary diversion after radical 
cystectomy; ileal conduit continues to be the most 
common form of urinary diversion
 
[1] [2].  
Improvements in surgical techniques and 
modern perioperative care have substantially 
decreased the rate of perioperative complications and 
lowered the operative mortality rate. However, this 
procedure remains complication-prone and is 
associated with significant perioperative and long-term 
morbidity ranging from 19% to 64% according to 
different series [3].
 
In several large series, the overall 
recurrence-free survival at five years for patients 
undergoing cystectomy approaches 70%, ranging 
from 50 to 60% for stage 3 or 4 tumours and 89 % for 
stage 2 tumours
 
[3] [4]. 
Countless retrospective studies 
unquestionably support radical cystectomy excellent 
oncologic outcomes and satisfactory postoperative 
quality of life (QoL) at long-term follow-up. Although 
much of the clinical evidence coming from these 
studies are of low quality, major international 
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guidelines strongly recommend radical cystectomy as 
the elective treatment for muscle-invasive bladder 
cancer. For more than 30 years, the ileal conduit (IC) 
has been considered the ‘‘standard’’ urinary diversion 
method for most patients submitted to radical 
cystectomies. It is recognised as the most clinically 
adequate, reliable, and cost-effective solution.  
Some complications are strictly related to IC 
and have been distinguished between early (before 90 
days) and late (after 90 days). Early complication 
related to bowel complication such as intestinal 
anastomosis related, ureteral ileal anastomosis 
leakage, enteric fistula, bowel obstruction, prolonged 
ileus and conduit necrosis, whereas late complication 
related to stoma complication such as abdominal wall 
related, conduit stenosis, ureters enteric anastomosis 
stricture also Hydronephrosis, kidney failure, and 
metabolic changes [5].
  
This study aimed to investigate the clinical, 
pathological profile and complications related to 
radical cystectomy and ileal conduit patients with 
bladder cancer in Sanglah general hospital, Denpasar 
Bali.  
 
 
Methods 
 
From January 2013 to December 2016, there 
were 68 patients had been diagnosed with bladder 
cancer, 59 patient had the urothelial carcinoma, four 
patient had squamous cell carcinoma, five patient had 
adenocarcinoma. 30 patient already underwent 
chemotherapy, three patient had a partial cystectomy, 
and 24 patient (35.3%) had been performed radical 
cystectomies with following ileal conduit type or 
Bricker’s procedure type of urinary diversion, remain 
of it 11 patient (16.17%) had refused for treated. We 
carried out a retrospective study by reviewing the 
medical records of those 24 patients who treated with 
open radical cystectomies and ileal conduit type for 
urinary diversion. Follow up on those patients 
continued until January 2017. Data were collected 
through follow-up visits in outpatient clinics, evaluated 
by the following history included: age and comorbid 
(diabetes mellitus, hypertension, ischemic heart 
disease), operative details, histopathological type and 
grading also the history of neoadjuvant and adjuvant 
chemotherapy were recorded. We were also collecting 
postoperative early complications and late 
complications, at early complications, we divided into 
diversion related and not diversion related. With a 
minimum follow up 6-month patients were routinely 
seen in the outpatient clinic for stoma care, oncologic 
follow-up and also late complications after the 
procedure. 
 
Results 
 
Pre characteristics database showed 20 
patients (83.4%) was male, with the median age was 
57.3 y.o (32-77 y.o). All patients came to the hospital 
with chief complained initiated gross hematuria or 
blood clot retention, some of them complained of 
dysuria too, 33.3% patients had suffered from UTI 
(Urinary Tract Infection), 20.83% patients had bladder 
stone and some suffered systemic comorbidities such 
as cardiovascular diseases (29.2%), type II diabetes 
Mellitus (8.3%) and prior renal failure (37.5%). Based 
on clinical, 20.83% patients with staging cT2 tumour 
preoperatively, 33.3% patients had cT3 and 45.83% 
with cT4. There is only two patient (8.33%) had 
neoadjuvant chemotherapy.  
Table 1: Preoperative characteristic of bladder cancer patients 
who underwent radical cystectomies 
Variables Preoperative Result  
Sex (%) 
 Male 
 Female 
Mean age (range) 
Chief complain 
Local comorbidities (%) 
 UTI 
 Bladder stone 
 Bladder diverticula
 
 Surgical history of bladder 
Systemic comorbidities (%)  
 Cardiovascular comorbidity 
 DM type II 
 Chronic kidney failure 
Clinical staging (%) 
 T1 
 T2 
 T3 
 T4 
 Neoadjuvant Chemotherapy 
 
20 (83.4%) 
4 (16.6%) 
± 57.3 y.o (33–77 y.o) 
Hematuria (100%) 
 
8 (33.3%) 
5 (20.83%) 
2 (8.34%) 
3 (12.5%) 
 
7 (29.2%) 
2 (8.3%) 
9 (37.5%) 
 
- 
5 (20.83%) 
8 (33.3%) 
11 (45.83%) 
2 (8.33%) 
 
 
From perioperative data showed that the 
mean operation time was 351 minutes (310-435 
minutes), and mean intraoperative blood loss was 
1070cc (500 – 2500cc). 91.66% of patients performed 
bilateral pelvic lymph dissection. There was, two 
patients (8.33%) died one month after surgery 
because of sepsis. 
Table 2: Perioperative data from patients with radical 
cystectomies 
Variables Perioperative Result 
Mean Operation time (range) 
Mean intra operative blood loss (range) 
Pelvic Lymph dissection bilateral 
 Yes 
 No 
± 351minutes ( 310-435 minutes) 
±1070 cc (500-2500 cc) 
 
22 (91.66%) 
2 (8.34%) 
 
 
From postoperative and follow up data in the 
outpatient clinic we found that 50% patient showed 
pT4, and 50% had pT2, there is no pT3, 83.34% 
patients showed with transitional Cell ca (TCC) and 
one patient with a synchronous tumour with TCC and 
acinar adenocarcinoma prostate, 70.83% was high-
grade carcinoma. In all cases, nine patients (37.5%) 
undergo adjuvant chemotherapy.  
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Table 3: Postoperative characteristics data from patients with 
radical cystectomies 
 Variables Postoperative
 Result 
Pelvic Lymph dissection (%) 
 Yes 
 No 
Pathological staging (%) 
 pT1 
 pT2 
 pT3 
 pT4 
 Lymph Node Pathological 
 pN0 
 pN1 
 pN2 
 pNx 
Pathological type (%) 
 TCC 
 SCC 
 Adenocarcinoma 
Pathological grading (%) 
 Low grade 
 Moderate grade 
 High grade 
Adjuvant Chemotherapy 
 
22 (91.66) 
2 (8.34) 
 
- 
12 (50%) 
- 
12 50%) 
 
13 (54.2%) 
6 (25%) 
3 (12.5%) 
2 (8.3%) 
 
20 (83.34%) 
3 (12.5%) 
1 (4.16%) 
 
4 (16.7%) 
3 (12.5%) 
17(70.83%) 
9 (37.5) 
 
 
About the postoperative complication, we 
divided into an early and late complication, which 
early was taken 3 months after surgery and late was 
taken 3 months after surgery. Early complication 
related to bowel complication such as intestinal 
anastomosis related, ureteral ileal anastomosis 
leakage, enteric fistula, bowel obstruction, prolonged 
ileus and conduit necrosis, whereas late complication 
related to stoma complication such as abdominal wall 
related, conduit stenosis, ureters enteric anastomosis 
stricture also Hydronephrosis, kidney failure, and 
metabolic changes [5]. From the early complication 
include one patient had fistula enterocutan and 20.8% 
suffered prolonged ileus. Fifteen patients still alive in 
minimum follow up 12 months had a survival rate of 
84%. Mortality rate 20.8%, causes of death shown at 
table 4: one patient (4.16%) died 2 months after 
surgery because of ileus, 0ne patient (4.16%) died 1 
year after surgery because of recurrence and 
metastasis, and one patient (4.16%) died 21 months 
after surgery because of metastasis. Recurrency 
happens in five patients (20.8%), 4 with local 
recurrence and 1 with distant metastasis. The distant 
metastasis went through bone metastasis.
 
Table 4: Complication characteristics from patients with radical 
cystectomies 
Variables Result 
Early complication (%) 
Bowel related 
 Prolonged ileus 
 Fistula enterocutan 
 Sepsis (<3 month) 
 
Late Complication (%) 
Stoma-related
 
 Ureter stenosis 
 Electrolytes imbalance
 
 Wound dehiscence 
 A hernia incisional
 
  
Survive (>12 months)
 
Mortality rate 
 
Cause of Mortality rate 
 Sepsis 
 Metastasis 
 Ileus 
Recurrence
 
 
 
5 (20.8%) 
1 (4.16%) 
2 (8.34%) 
 
 
 
1 (4.16%) 
1 (4.16%) 
5 (20.8%) 
1 (4.16%) 
 
15 (84%) 
5 (20.8%) 
 
 
2 (8.34%) 
2 (8.34%) 
1 (4.16%) 
5 (20.8%) 
 
 
Discussion 
 
Radical cystectomy with pelvic lymph node 
dissection provides the best cancer-specific survival 
for muscle-invasive urothelial cancer and is the 
standard treatment, with 10-year recurrence-free 
survival rates of 50–59% and overall survival rates of 
around 45%
 
[6] [7] [8] [9]. The primary goals in the 
selection of a urinary diversion are to provide the 
patient with the diversion that results in the best local 
cancer control, the lowest potential for both short and 
long-term complications and the best quality of life 
while still allowing the timely completion of 
chemotherapy and therapeutic goals
 
[10]. Recently, 
many options for urinary diversion after radical 
cystectomy, but in our study ileal conduit still 
considered the "standard" urinary diversion for 
nonmetastatic bladder cancer. It is universally 
recognised as being the most clinically adequate, cost 
and time effective, and reliable solution in long-term. 
Other option for urinary diversion like neobladder still 
not yet performed in our institution because of for 
developing country like Indonesia, many patients with 
bladder cancer came from intermediate low social 
state and poor education so that ileal conduit type 
more acceptable than neobladder. However, a form of 
incontinent urinary diversion (ICUD) is the method of 
choice in elderly patients, and in those with high 
comorbidity (American Society of Anaesthesiologist 
Score [ASA] > 3), Ileal Conduit remains the preferred 
method
 
[11]. 
Radical cystectomy with ileal conduit type of 
diversion entails simultaneous surgery on the urinary 
tract, intestines, and lymph nodes; hence, 
complications frequently occur after this extensive 
procedure. According to the literature, the incidence of 
such secondary conditions varies widely (from 19% to 
64%). Hollenbeck et al., studied data on 2538 cases 
obtained from the National Quality Improvement 
Program, which is a prospective quality management 
initiative of 123 US Department of Veterans Affairs 
medical centres, and the results of that evaluation 
showed that 30.5% of the patients had at least one 
complication at 30-day follow-up after RC [12] [13] 
[14].
 
From postoperative data and follow up outpatient 
clinic we found that 50% patient had pT4, and 50% 
had pT2, there is no pT3. Based on pathological result 
20 patient (83.34%) had urothelial carcinoma, 3 
patient (12.5%) had squamous cell carcinoma, and 1 
patient (4.1%) had adenocarcinoma, and one patient 
had a synchronous tumour with TCC and acinar 
adenocarcinoma prostate, 70.83% was high-grade 
carcinoma, while Enein et al. study showed TCC 
59.5%, SCC 36%, and Adenocarcinoma 2%, 
moderate grade 56.5% and T3 46.5% [15].
 
Fifty percent of our patients came with the 
high stadium, more than stadium II of cancer, and not 
few of them came with metastatic bladder cancer. At 
the time of diagnosis, almost all high-grade bladder 
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cancer are muscle invasive. It is because of minimum 
information about cancer especially bladder cancer in 
our society, and low awareness about it, so there 
always almost all of the patients came with late 
bladder cancer. The decision to perform immediate 
radical surgery depends on several factors, including 
ASA, age, and life expectancy. 

 
In our study the average patient loses 500ml 
to 2500 ml of blood during RC, indicating that this type 
of surgery often leads to considerable loss of blood 
and, consequently, to transfusions. Blood transfusions 
are associated with major complications and with high 
total hospital costs for RC
 
[16] [17]. 
It is noteworthy that all patients in this study 
had a minimum follow up, and some of them, not well 
recorded and loss of follow up also. From 
complication data, we divided into an early and late 
complication, early taken before 3 months after 
surgery and late is made 3 months after surgery. 
From the early complication, only one patient had 
ureter stenosis, 20.8% had wound dehiscence, 20.8% 
patients had prolonged ileus, and 1 (4.1%) had an 
incisional hernia. The earliest complications in our 
study were wound dehiscence, it is probably because 
of bad hygiene, hypoalbuminemia, late immobilisation, 
and some of our patients had systemic comorbidities 
like diabetes mellitus type II. Kim et al., have searched 
about early and late complication, their study showed 
during the median follow-up of 46.6 months, early, 
and late morbidities were 29.5% and 19.8%, and 
complication-related mortalities were 2.2 and 6.6%, 
respectively
 
[18]. 
Feared complications immediately after RC 
include internal anastomotic leak and urinary 
extravasation caused by anastomotic or reservoir 
leakage. In a prospectively randomised study
 
[19], 
perioperative stenting was found to decrease urinary 
leakage. Even in the absence of available evidence, it 
seems wise to recommend that drains be left in place 
until anastomotic integrity is established in the 
intestinal and urinary tracts. Due to the relatively low 
extravasation rate associated with RC, it is probably 
not necessary to perform routine postoperative 
urography or stentograms in patients with a normal 
postoperative course [16]. Gastrointestinal events 
probably represent the most common type of 
complication during the period after RC. Postoperative 
intestinal anastomotic leakage has been described in 
3% of patients
 
[20], Compared to urinary or intestinal 
leakage, intestinal obstruction is more common as a 
complication of RC, and it was found to affect 23% of 
patients in a recent cystectomy series
 
[20]. Infectious 
events are the second most common complications of 
RC, constituting 25% of all early complications within 
90 d of the surgery, according to a recent investigation
 
[20]. Adequate perioperative antimicrobial prophylaxis 
to prevent postoperative infectious complications is 
standard practice in the care of surgery patients, but 
information is lacking concerning the optimal schedule 
in conjunction with RC. Wound-related complications, 
primarily dehiscence in the early postoperative period, 
constitute 15% of all early complications of RC
 
[20]. 
However, when using a midline incision, several 
factors might affect the incidence of wound 
separation, including operational, technical issues. In 
contrast, a recent meta-analysis of 23 randomised 
studies comparing the interrupted and continuous 
methods of laparotomy wound closure demonstrated 
that the interrupted technique was associated with 
significantly less dehiscence (odds ratio: 0.58), 
whereas there was no difference concerning hernia 
risk [21]. 
In our study, Recurrence has arisen in 5 
cases, 4 with local recurrence and 1 with distant 
metastasis while in a study by Jian et al., there was 
local recurrence in 9 patients (5.3%), distant 
metastasis in 23 patients (13.5%) and both in two 
patients (1.2%)
 
[21]. 
Five patients (20.8%) had died from various 
causes; one patient (4.16%) died 2 months after 
surgery because of ileus, two patient (8.33%) died 
before one month after surgery because of sepsis, 
0ne patient (4.16%) died 1 year after surgery because 
of recurrence and metastasis, and 0ne patient 
(4.16%) died 21 months after surgery because of 
metastasis, while in the study of Jian et al., there were 
28 of 171 patients (16.4%) had died from various 
causes, 20 from metastasis and 8 from causes 
unrelated to the tumor (two from upper gastrointestinal 
bleeding, two from myocardial infarction, two from 
pneumonia, one from stroke and one from a car 
accident)
 
[21]. 
Improvements in surgical techniques and 
modern perioperative care have substantially 
decreased the rate of perioperative complications and 
lowered the operative mortality rate. However, this 
procedure remains complication-prone and is 
associated with significant perioperative and long-term 
morbidity ranging from 19% to 64% according to 
different series. The Ileal conduit remains the most 
frequent form of urinary diversion, published first in 
1952 and became popular and is still the Gold 
Standard. The technique proved to be quick, safe and 
straightforward compared to neobladder [11]. 
In conclusion, the Ileal Conduit can still be 
considered an appropriate surgical solution after 
Radical Cystectomy in most patients because of the 
relative simplicity of the surgical technique, the 
acceptable complication rate, and the satisfactory 
postoperative Quality of Life. Our patients still need to 
be follow up till next 5-10 years after surgery, to 
maintain the late complications after surgery. After all, 
yet to be our job to give more education and 
information about cancer issue, to raise awareness 
and to reduce morbidity, and gained the better quality 
of life for cancer patients. Careful patient selection, 
strict adherence to proper surgical technique and 
appropriate life-long follow-up are of paramount 
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importance in the successful management of patients 
undergoing radical cystectomy for bladder cancer. 
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